By the same authors

From the same journal

Chiral liquid crystal dopants derived from optically active drugs

Research output: Contribution to journalArticle

Published copy (DOI)

Author(s)

Department/unit(s)

Publication details

JournalLIQUID CRYSTALS
DatePublished - Nov 2009
Issue number10-11
Volume36
Number of pages7
Pages (from-to)1193-1199
Original languageEnglish

Abstract

In this article we examine the possibility of using chiral pharmaceuticals as reactive substrates in the synthesis of chiral liquid crystals because chiral drugs usually have reproducibly high chemical and optical purities which are important for applications of chiral liquid crystals. Thus we combined racemic and S-ibuprofen, racemic and S-ketoprofen and S-naproxen with a fluoroterphenyl promesogenic material in order to create bent core materials which we predicted would have helical twisting powers depending on the extent of the molecular bending.

    Research areas

  • pharmaceuticals, helical twisting power, chiral nematic materials, PHASES, POWER, ACID

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations